[Federal Register Volume 81, Number 149 (Wednesday, August 3, 2016)]
[Pages 51216-51217]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2016-18372]



Advisory Committee on the Medical Uses of Isotopes: Meeting 

AGENCY: U.S. Nuclear Regulatory Commission.

ACTION: Notice of meeting.


SUMMARY: NRC will convene a meeting of the Advisory Committee on the 
Medical Uses of Isotopes (ACMUI) on October 6-7, 2016. A sample of 
agenda items to be discussed during the public session includes: An 
update on medical-related events; a discussion on the reporting of 
medical events for various

[[Page 51217]]

modalities; a discussion on the licensing guidance for yttrium-90 
microsphere brachytherapy; a discussion on the training and experience 
requirements for authorized individuals for various modalities; a 
presentation from Spectrum Pharmaceuticals, Inc. on the training and 
experience requirements for alpha and beta emitters; an update on the 
worldwide supply of molybdenum-99; and a discussion on the licensing 
guidance for the NorthStar[supreg] Generator. The agenda is subject to 
change. The current agenda and any updates will be available at http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2016.html or by 
emailing Ms. Michelle Smethers at the contact information below.
    Purpose: Discuss issues related to 10 CFR part 35 Medical Use of 
Byproduct Material.
    Date and Time for Open Sessions: October 06, 2016, from 8:00 a.m. 
to 3:00 p.m. and October 07, 2016, from 8:00 a.m. to 4:00 p.m.
    Data and Time for Closed Sessions: October 06, 2016, from 7:00 a.m. 
to 8:00 a.m. and from 3:00 p.m. to 5:00 p.m.
    Address for Public Meeting: U.S. Nuclear Regulatory Commission, Two 
White Flint North Building, Room T2-B3, 11545 Rockville Pike, 
Rockville, Maryland 20852.
    Public Participation: Any member of the public who wishes to 
participate in the meeting in person or via phone should contact Ms. 
Smethers using the information below. The meeting will also be webcast 
live: video.nrc.gov.

[email protected], telephone: (301) 415-6711.

Conduct of the Meeting

    Philip O. Alderson, M.D., will chair the meeting. Dr. Alderson will 
conduct the meeting in a manner that will facilitate the orderly 
conduct of business. The following procedures apply to public 
participation in the meeting:
    1. Persons who wish to provide a written statement should submit an 
electronic copy to Ms. Smethers using the contact information listed 
above. All submittals must be received by October 3, 2016, and must 
pertain to the topic on the agenda for the meeting.
    2. Questions and comments from members of the public will be 
permitted during the meeting, at the discretion of the Chairman.
    3. The draft transcript and meeting summary will be available on 
ACMUI's Web site http://www.nrc.gov/reading-rm/doc-collections/acmui/meetings/2016.html on or about November 22, 2016.
    4. Persons who require special services, such as those for the 
hearing impaired, should notify Ms. Smethers of their planned 
    This meeting will be held in accordance with the Atomic Energy Act 
of 1954, as amended (primarily Section 161a); the Federal Advisory 
Committee Act (5 U.S.C. App); and the Commission's regulations in Title 
10 of the Code of Federal Regulations, part 7.

    Dated at Rockville, Maryland, this 28th day of July, 2016.
Andrew L. Bates,
Advisory Committee Management Officer.
[FR Doc. 2016-18372 Filed 8-2-16; 8:45 am]